查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198497

中风后治疗软件市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

Stroke Post Processing Software Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2022 年至 2027 年），中风后治疗软件市场的复合年增长率预计为 8.55%。

在 COVID-19 大流行期间，大多数医院护理转向护理冠状病毒感染的患者，导致短暂且略微放缓的增长。 然而，随着 COVID 患者开始出现中风等脑部相关问题，对中风后治疗软件的需求增加。 然而，由于中风是一种敏感疾病，市场状况很快就恢復了。 帮助管理中风后的软件的可用性使一线工作人员能够做出更好的治疗决策。 由于技术进步，使用人工智能的中风管理软件正在以相当大的势头传播。 在 COVID-19 爆发之初，人们注□□意到中风患者的住院率有所下降。 这是因为我害怕在隔离和坐月子期间被感染。 许多地区都记录了急性中风住院人数的减少，这表明许多轻度和重度中风患者也避免了住院治疗。 根据美国国立卫生研究院 2020 年的数据，自发布与 COVID-19 相关的封锁令以来，得克萨斯州中部和南部因急性中风护理而入院、治疗和出院的人数急剧减少。我在这里。

随着中风次数的增加，中风管理系统和软件的需求量越来越大。 根据美国疾病控制和预防中心 (CDC) 的数据，到 2020 年，美国六分之一的死亡人数预计将死于中风。 该软件系统改善了中风患者的预后。 基于 AI 人工智能的方法可帮助中风专家检测大血管闭塞，从而加快患者转诊和转移速度。 中风后治疗软件可实现更有效的途径、更快的治疗决策并改善患者的治疗效果。 技术改进，特别是在医疗保健 IT 解决方案领域，显着提高了医疗保健专业人员对软件的采用，并降低了中风后问题的可能性。

中风后护理软件生成更详细的图像和同步数据，以帮助诊断中风的影响和进展，帮助医生更快地做出临床决策。 因此，对其进行质量升级和更新投资将对市场增长产生重大影响。 例如，GE Healthcare 的 ViewPoint 6 Direct Connect 医院软件通过自动填充超声读数和将详细信息直接报告到放射学报告系统来减少听写，从而使医生的生活更轻鬆。 根据美国疾病控制与预防中心的数据，2022 年美国每 40 秒就会发生一次中风。 此外，每 3.5 分钟就有一人死于中风。 推动发达国家和新兴国家采用医疗保健 IT 解决方案的政府政策是使该行业能够改善医疗保健成果的关键因素。 医疗保健意识的提高、糖尿病患者数量的增加、烟草使用者数量的增加以及老年人口的增加是推动市场扩张的因素。

此外，中风检测和治疗方面的技术发展正在推动市场增长。 随着医疗保健行业继续依赖技术突破，人工智能和机器学习预计将变得司空见惯。 这为更复杂的检测、诊断和治疗中风患者的方法带来了希望。 这将迫使服务提供商部署先进的中风后治疗软件。 然而，高昂的诊断和治疗成本以及缺乏报销监管预计将阻碍市场扩张。 另一方面，中风管理领域的持续研究和开发将为市场扩张提供有利可图的潜力。 随着人工智能和其他技术发展的普及，它们在关键医疗保健环境中的应用越来越广泛。 所有这些因素都在推动预测期内市场的加速增长。

中风后治疗软件市场趋势

脑卒中后治疗软件市场形态，MRI领域有望占据主要市场份额

中风是一种严重影响患者生活质量的衰弱性疾病，如果不及时治疗尤其如此。 中风的早期检测可以减少患者残废的机会。 MRI 图像提供头部的清晰视图，包括组织和血管。 MRI 使用磁场和射频脉衝来揭示大脑中的任何变化。 市场按方式分为 CT 扫描和 MRI。 磁共振成像 (MRI) 是一种有用的诊断工具，可用于检测影响血管和大脑的疾病，例如脊柱病变、癌症和中风。 脊柱疾病、癌症和中风患病率的上升预计将对市场的扩张做出重大贡献。 对快速有效的诊断治疗的需求不断增长，预计将推动 MRI 设备的使用。 这些 MRI 机器安装在多个国家/地区。 根据 2021 年 12 月的国家卫生服务更新，从 2020 年 9 月到 2021 年 8 月的 12 个月内，英格兰报告了 4030 万次影像学检查。 其中，2021 年 8 月报告了 322 万次成像测试。 2021 年 8 月，X 线平片检查数量最多（160 万例），其次是超声诊断（超声检查，72 万例）、计算机轴向断层扫描（CT 扫描，49 万例）和磁共振成像（MRI， 290,000 例）。

MRI 行业的发展得益于开放式 MRI、可视化软件和超导磁体等诊断方法的进步。 MRI 技术的大部分最新进展都归功于软件。 这些软件创新可加快对比增强扫描并促进成像程序。 不断发展的 MRI 技术能够快速检测和诊断中风，有助于进行适当的管理。 扩散和扩散张量成像与纤维束成像、由 MR 波谱学组成的神经成像、灌注成像和采用大胆技术的功能成像预计将在整个预测期内推动市场增长。 此外，随着术中 MRI 的发展取得进展，市场有望在整个预测期内扩大，并且已开始用于神经外科等各种应用。

北美将占据很大的市场份额，预计在预测期内也会如此

预计北美将占据很大一部分市场。 这是由于糖尿病等慢性病发病率的增加、对中风管理设备的需求增加、配备训练有素的医护人员的先进医疗设施的可用性以及许多大公司的研发活动增加。 ，部分原因是政府增加了对医疗保健系统的投资。 该地区慢性病尤其是神经系统疾病的患病率不断上升，这增加了对图像分析的需求。 预计该地区将在预测期内保持其主导地位。

技术进步和慢性病发病率的增加预计将在预测期内推动市场扩张。 因素包括中风患病率上升、患者人数显着增加以及政府支持投资在该地区改善医疗保健设施。 根据美国卫生与公共服务部 2020 年数据，中风每年影响美国超过 795,000 人。 因此，美国和加拿大的医院和专业组织越来越多地使用中风后治疗软件来帮助检测动脉瘤和其他血管疾病。

随着人工智能在中风诊断和治疗中的应用取得进展，市场有望扩大。 由于患者数据处理新技术的引入，市场有望增长。 通过根据定制数据建立疾病模式，经过处理的患者数据可以专注于有患病风险的特定人群。 市场先驱可以通过提供可持续的医疗保健解决方案、使产品和服务更容易获得以及应对数字中断来扩大他们在新兴市场的影响力。

中风后治疗软件市场竞争对手分析

中风后治疗软件市场分散且竞争激烈，由几家大型企业组成。 从市场份额的角度来看，一些主要参与者目前主导着市场。 目前的市场主导者包括 Brainomix、Constant Therapy、Cozi、General Electric Company、Koninklijke Philips NV、Medisafe、RAPIDAI、Siemens Healthineers、Tactus Therapy Solutions Ltd 和 Viz.ai Inc。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 快速的技术进步
    • 增加政府对基因组学的资助
    • 个性化医疗的传播
  • 市场製约因素
    • 缺乏技术工人
    • 设备成本高
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按技术
    • 聚合□炼式反应 (PCR)
    • 下一代测序 (NGS)
    • 微阵列
    • 其他
  • 按产品类型
    • 设备
    • 试剂和耗材
    • 服务
  • 最终用户
    • 药物发现
    • 诊断研究所
    • 学术研究所
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • QIAGEN
    • Quest Diagnostics Incorporated
    • F. Hoffmann-La Roche Ltd
    • Illumina, Inc.
    • Novogene Corporation
    • PerkinElmer Inc.
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies
    • Promega Corporation
    • Luminex Corporation

第七章市场机会与未来趋势

简介目录
Product Code: 90830

The Stroke Post Processing Software Market is projected to register a CAGR of 8.55% during the forecast period (2022-2027).

During the COVID-19 pandemic, most of the hospital-based care was shifted to caring for coronavirus-infected patients, putting a transient and slight dent in growth. However, as more COVID patients suffered strokes and other brain-related issues, the demand for stroke post-processing software grew. Due to the sensitive nature of the stroke, however, market conditions recovered quickly. Frontline workers can now make better treatment decisions because of the availability of helpful post-stroke management software. AI-Artificial intelligence-driven stroke management software has seen a considerable surge in popularity because of technological improvements. Reduced hospital admissions of stroke patients were noted during the initial COVID-19 outbreak. It was because people were afraid of infection during a period of segregation and lockdown. A decline in acute stroke hospital admissions has been recorded in many regions, indicating that many patients with mild and severe strokes are also avoiding hospitalization. According to data from the National Institute of Health-2020, patient admission, treatment, and discharge volumes for acute stroke therapy in central and south Texas have reduced dramatically since COVID-19-related lockdown orders were issued.

Stroke management systems and software are in higher demand as the number of strokes rises. According to the Centers for Disease Control and Prevention (CDC), stroke is expected to account for one in every six deaths in the United States by 2020. The software systems provide better treatment outcomes for stroke victims. The AI-Artificial intelligence-based approach aids stroke specialists in detecting major vascular occlusions, allowing patients to be referred and transferred more quickly. The use of stroke post-processing software allows for the creation of more efficient pathways, faster treatment decisions, and improved patient outcomes. Technological improvements, particularly in the realm of healthcare IT solutions, have considerably improved software adoption by healthcare professionals while also lowering the likelihood of post-stroke problems.

The stroke post-processing software generates more detailed images with synchronized data, assisting in the diagnosis of the stroke's effect or progression and allowing physicians to make more rapid clinical judgments. As a result, investing in it to improve quality and updates can have a huge impact on market growth. For instance, Hospital software ViewPoint 6 Direct Connect by GE Healthcare helps reduce dictation by auto-populating ultrasound measurements and report details directly into the radiology reporting system and makes the physicians' work easier. According to the Centers for Disease Control and Prevention-2022, a stroke occurs every 40 seconds in the United States. Someone dies of a stroke every 3.5 minutes. In both developed and emerging nations, government policies that promote the overall adoption of healthcare IT solutions to improve healthcare outcomes operate as a primary reinforcing factor for the industry. Increased healthcare awareness, an increase in the frequency of diabetes, an increase in the number of tobacco users, and an increase in the senior population are all driving market expansion.

Furthermore, technical developments in stroke detection and treatment add to the market's growth. Artificial intelligence and machine learning are projected to become commonplace as the healthcare business continues to rely on technological breakthroughs. More sophisticated ways of detecting, diagnosing, and treating stroke patients are expected because of this. This will force service providers to implement highly advanced stroke post-processing software. However, high diagnostic and treatment costs, as well as a lack of reimbursement regulations, are projected to limit market expansion. On the other hand, continuous R&D in the field of stroke management is likely to provide the profitable potential for market expansion. Artificial intelligence and other technological developments have become more widely adopted across important healthcare settings as their penetration has increased. All the factors contribute to accelerating the market growth during the forecast period.

Stroke Post Processing Software Market Trends

The MRI Segment is Expected to Hold a Major Market Share for Modality in the Stroke Post Processing Software Market

A stroke is a debilitating ailment that has a significant impact on a patient's quality of life, especially if it is not treated promptly. Early detection of a stroke can lessen the likelihood of the patient surviving with a handicap. The head, including the tissue and blood vessels, can be seen clearly with MRI imaging. Magnetic fields and radiofrequency pulses are used in an MRI to reveal any alterations in the brain. The market is divided into CT scan and MRI segments based on modality. Magnetic resonance imaging (MRI) is a useful diagnostic tool for detecting disorders such as lesions in the spine, cancers, and strokes that affect the blood vessels and brain. The rising prevalence of lesions in the spine, cancers, and stroke disorders is likely to contribute significantly to market expansion. The increasing demand for speedy and effective diagnostic treatments is projected to drive MRI machine usage. These MRI equipment are being installed in several nations. According to the National Health Service updates from December 2021, there were 40.3 million imaging tests reported in England in the 12 months from September 2020 to August 2021. Of these, 3.22 million imaging tests were reported to have taken place in August 2021. In August 2021, Plain Radiography (X-ray) was most common (1.6 million), followed by Diagnostic Ultrasonography (Ultrasound, 0.72 million), Computerized Axial Tomography (CT Scan, 0.49 million), and Magnetic Resonance Imaging (MRI, 0.29 million).

The MRI industry is growing because of advancements in diagnostic approaches such as open MRI, visualization software, and superconducting magnets. The majority of the recent advancements in MRI technology have been in software. These software innovations make contrast scans faster and the imaging procedure easier. Growing MRI technology enables the fast detection and diagnosis of stroke and helps in proper management. Diffusion and diffusion tensor imaging with tractography, neuroimaging comprising MR spectroscopy, perfusion imaging, and functional imaging employing the bold technique are projected to drive market growth throughout the forecast period. Moreover, the market is predicted to increase due to the increasing development of intraoperative MRI and its use in various applications such as neurosurgery throughout the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to account for a sizable portion of the market. This is due to an increase in the incidence of chronic diseases like diabetes, an increase in demand for stroke management devices, the availability of advanced healthcare facilities with trained medical professionals, an increase in the number of R&D activities with a large presence of key players, and an increase in government investment in the healthcare system. The rising prevalence of chronic disorders, particularly neurological ailments, in this region drives up demand for imaging analysis. Throughout the predicted period, the region is likely to maintain its supremacy.

During the projected period, technological advancements combined with an increase in the incidence of chronic illnesses are expected to drive market expansion. Factors such as the increased stroke prevalence, massive patient population expansion, and supportive government investments in the creation of improved healthcare facilities in the region. Stroke affects more than 795,000 people in the United States each year, according to the United States Department of Health and Human Services 2020. As a result, hospitals and specialized institutions in the United States and Canada are increasingly using stroke post-processing software to help detect aneurysms and other vascular diseases.

The market is expected to benefit from the increased usage of artificial intelligence in the diagnosis and treatment of strokes. The market is expected to rise due to the introduction of newer technologies for patient data processing. By establishing a disease pattern from the tailored data, the processed patient data can focus on a specific group of people at risk of acquiring diseases. Market companies can expand their presence in developing countries by delivering sustainable healthcare solutions, making their products and services more accessible, and addressing digital difficulties.

Stroke Post Processing Software Market Competitor Analysis

The Stroke Post Processing Software Market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Brainomix, Constant Therapy, Cozi, General Electric Company, Koninklijke Philips NV, Medisafe, RAPIDAI, Siemens Healthineers, Tactus Therapy Solutions Ltd, and Viz.ai Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Technological Advancement
    • 4.2.2 Increased Government Funding towards Genomics
    • 4.2.3 Growing Adoption of Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Labor
    • 4.3.2 High Cost of the Instruments
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Polymerase Chain Reaction (PCR)
    • 5.1.2 Next Generation Sequencing (NGS)
    • 5.1.3 Microarrays
    • 5.1.4 Others
  • 5.2 By Product Type
    • 5.2.1 Instruments
    • 5.2.2 Reagents and Consumables
    • 5.2.3 Services
  • 5.3 By End-user
    • 5.3.1 Drug Discovery
    • 5.3.2 Diagnostic Laboratories
    • 5.3.3 Academic Research Centers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 QIAGEN
    • 6.1.2 Quest Diagnostics Incorporated
    • 6.1.3 F. Hoffmann-La Roche Ltd
    • 6.1.4 Illumina, Inc.
    • 6.1.5 Novogene Corporation
    • 6.1.6 PerkinElmer Inc.
    • 6.1.7 Bio-Rad Laboratories
    • 6.1.8 Thermo Fisher Scientific, Inc.
    • 6.1.9 Agilent Technologies
    • 6.1.10 Promega Corporation
    • 6.1.11 Luminex Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS